Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Polycystic Ovary Syndrome 1 Multiple Endocrine Neoplasia Type 1 1 Endometrial Neoplasms 1

Interventions

Metformin 21 Inositol 13 Letrozole 9 Exercise 5 Surveys and Questionnaires 4 Clomiphene 4 Tablets 3 Estradiol 3 semaglutide 2 maltodextrin 2 drospirenone and ethinyl estradiol combination 2 Spironolactone 2 Progesterone 2 Ethinyl Estradiol 2 Diet Therapy 2 Contraceptives, Oral, Combined 2 Caloric Restriction 2 Acupuncture Therapy 2 salicylsalicylic acid 1 mirabegron 1 etonogestrel 1 drospirenone 1 dapagliflozin 1 cetrorelix 1 Walking 1 Tirzepatide 1 Thyroxine 1 Thioctic Acid 1 Tamoxifen 1 Sodium-Glucose Transporter 2 Inhibitors 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Polycystic Ovary Syndrome × Levonorgestrel × 1 year × Clear all

NCT03043924 2025-12-11

MRI-PCOS

University Hospital, Lille

Phase NA Completed

Polycystic Ovary Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon ⚡